AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Prempro 0.45 mg/1.5 mg a low-dose hormone therapy option.
2003 AUG 7 - (NewsRx.com & NewsRx.net) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced the availability of Prempro (conjugated estrogens [CE]/ medroxyprogesterone acetate [MPA] tablets) 0.45 mg/1.5 mg, the company's new low-dose hormone therapy.
Prempro 0.45 mg/1.5 mg has been shown to be as effective as the current standard dose in relieving menopausal symptoms, yet contains 28% less estrogen and 40% less progestin.
"The availability of these new low dose hormone therapy options is good news for women seeking treatment for their moderate to severe menopausal symptoms and who are concerned about protecting against early menopausal bone loss," said Dr. Victoria Kusiak, vice president of global medical affairs and North American medical director for Wyeth Pharmaceuticals. "The FDA and other health experts recommend that women who are taking postmenopausal therapy take the lowest effective dose for the shortest duration consistent with treatment goals and risks for the individual woman."
Prempro is the most commonly prescribed brand of combination estrogen plus progestin therapy (also known as hormone therapy, or HT). Prempro 0.45 mg/1.5 mg provides an improved bleeding profile and symptom relief comparable to the most frequently prescribed strength of Prempro (0.625 mg/2.5 mg). Prempro 0.45 mg/1.5 mg is indicated for use by women with a uterus; Premarin (conjugated estrogens ...
- Lowest Effective Dose of PREMPRO(TM) (0.3 mg/1.5 mg) Now Readily Available In...
- Press release article from: PR Newswire February 20, 2004 700+ words
...medroxyprogesterone acetate [MPA] tablets) - 0.3 mg/1.5 mg. PREMPRO 0.3 mg/1.5 mg contains 52 percent less estrogen and 40 percent less progestin than PREMPRO 0.625 mg/2.5 mg, and has been shown to be as effective...
- Now Available - PREMPRO 0.45 mg/1.5 mg - A New Low Dose Hormone Therapy Option;...
- Press release article from: PR Newswire July 1, 2003 700+ words
...new low dose hormone therapy. PREMPRO 0.45 mg/1.5 mg has been shown to be...as hormone therapy, or HT). PREMPRO 0.45 mg/1.5 mg provides an improved...of PREMPRO (0.625 mg/2.5 mg). PREMPRO 0.45 mg/1.5 mg is indicated...
- New Wyeth ad campaign touts Prempro.(Branded Drugs)(prempro 0.3-mg/1.5-mg...
- Magazine article from: Chain Drug Review September 27, 2004 700+ words
...the lowest effective dose of Prempro. The initiative educates women...symptoms. The campaign, featuring Prempro 0.3-mg/1.5-mg tablets, targets symptomatic...relief and bone protection that Prempro can provide to women who experience...
- Wyeth Launches National Advertising Campaign for Hormone Therapy Featuring the...
- Press release article from: PR Newswire August 16, 2004 700+ words
...2003, the company introduced PREMPRO 0.45 mg/1.5 mg, which contains 28...40 percent less progestin than PREMPRO 0.625 mg/2.5 mg. Introduced in 2004...tolerability of PREMPRO 0.3 mg/1.5 mg and PREMPRO 0.45 mg/1.5 mg are based...
- Prempro 0.3/1.5 (conjugated estrogens/medroxyprogesterone acetate, Wyeth).(New...
- Magazine article from: Internal Medicine News Meccatie, Elizabeth July 15, 2003 700+ words
...dose formulation approved earlier this year (Prempro 0.45/1.5) will be available this month...dose formulations that have been on the market, Prempro 0.625/2.5 mg and Prempro of 0.625/5.0. Prempro 0.625/5 was associated...
- New FDA approvals.(etanercept (Enbrel) from Amgen and Wyeth Pharmaceuticals,...
- Newspaper article from: Drug Utilization Review September 1, 2003 700+ words
...tablets (Prempro), containing 0.3 mg CE and 1.5 mg MPA. Prempro 0.3 mg/1.5 mg is approved for the treatment of moderate...that the FDA has expanded the approved uses for Prempro 0.45 mg/1.5 mg to include the prevention of postmenopausal...
- FDA panel okays revised osteoporosis indication for PremPro: discussion of WHI...
- Magazine article from: OB GYN News Mechcatie, Elizabeth November 1, 2003 700+ words
...osteoporosis indication for PremPro (conjugated estrogens/medroxyprogesterone...lower dose formulations of PremPro (0.45 mg/1.5 mg and 0.3 mg/1.5 mg) when they were approved...FDA and Wyeth, the maker of PremPro, made presentations on the...
- FDA Approves Wyeth's New Low Dose Prempro(TM) Lower Hormone Dose With Efficacy...
- Press release article from: PR Newswire March 13, 2003 700+ words
...also known as hormone therapy, or HT). Low dose Prempro, containing 0.45 mg CE and 1.5 mg MPA, provides favorable tolerability...comparable to the most frequently prescribed strength of Prempro, with 28 percent less estrogen and 40 percent less...